Werbrouck Joke, De Ruyck Kim, Duprez Fréderic, Veldeman Liv, Claes Kathleen, Van Eijkeren Marc, Boterberg Tom, Willems Petra, Vral Anne, De Neve Wilfried, Thierens Hubert
Department of Basic Medical Sciences, Ghent University, Ghent, Belgium.
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1187-95. doi: 10.1016/j.ijrobp.2008.08.073.
To investigate the association between dose-related parameters and polymorphisms in DNA DSB repair genes XRCC3 (c.-1843A>G, c.562-14A>G, c.722C>T), Rad51 (c.-3429G>C, c.-3392G>T), Lig4 (c.26C>T, c.1704T>C), Ku70 (c.-1310C>G), and Ku80 (c.2110-2408G>A) and the occurrence of acute reactions after radiotherapy.
The study population consisted of 88 intensity-modulated radiation therapy (IMRT)-treated head-and-neck cancer patients. Mucositis, dermatitis, and dysphagia were scored using the Common Terminology Criteria (CTC) for Adverse Events v.3.0 scale. The population was divided into a CTC0-2 and CTC3+ group for the analysis of each acute effect. The influence of the dose on critical structures was analyzed using dose-volume histograms. Genotypes were determined by polymerase chain reaction (PCR) combined with restriction fragment length polymorphism or PCR-single base extension assays.
The mean dose (D(mean)) to the oral cavity and constrictor pharyngeus (PC) muscles was significantly associated with the development of mucositis and dysphagia, respectively. These parameters were considered confounding factors in the radiogenomics analyses. The XRCC3c.722CT/TT and Ku70c.-1310CG/GG genotypes were significantly associated with the development of severe dysphagia (CTC3+). No association was found between the investigated polymorphisms and the development of mucositis or dermatitis. A risk analysis model for severe dysphagia, which was developed based on the XRCC3c.722CT/TT and Ku70c.-1310CG/GG genotypes and the PC dose, showed a sensitivity of 78.6% and a specificity of 77.6%.
The XRCC3c.722C>T and Ku70c.-1310C>G polymorphisms as well as the D(mean) to the PC muscles were highly associated with the development of severe dysphagia after IMRT. The prediction model developed using these parameters showed a high sensitivity and specificity.
研究DNA双链断裂修复基因XRCC3(c.-1843A>G、c.562-14A>G、c.722C>T)、Rad51(c.-3429G>C、c.-3392G>T)、Lig4(c.26C>T、c.1704T>C)、Ku70(c.-1310C>G)和Ku80(c.2110-2408G>A)中与剂量相关的参数和多态性与放疗后急性反应发生情况之间的关联。
研究人群包括88例接受调强放射治疗(IMRT)的头颈癌患者。使用不良事件通用术语标准(CTC)v3.0量表对黏膜炎、皮炎和吞咽困难进行评分。将人群分为CTC0-2组和CTC3+组,以分析每种急性效应。使用剂量体积直方图分析剂量对关键结构的影响。通过聚合酶链反应(PCR)结合限制性片段长度多态性或PCR单碱基延伸测定法确定基因型。
口腔和咽缩肌(PC)的平均剂量(D(mean))分别与黏膜炎和吞咽困难的发生显著相关。这些参数在放射基因组学分析中被视为混杂因素。XRCC3 c.722CT/TT和Ku70 c.-1310CG/GG基因型与严重吞咽困难(CTC3+)的发生显著相关。在所研究的多态性与黏膜炎或皮炎的发生之间未发现关联。基于XRCC3 c.722CT/TT和Ku70 c.-1310CG/GG基因型以及PC剂量建立的严重吞咽困难风险分析模型,其敏感性为78.6%,特异性为77.6%。
XRCC3 c.722C>T和Ku70 c.-1310C>G多态性以及PC肌肉的D(mean)与IMRT后严重吞咽困难的发生高度相关。使用这些参数建立的预测模型具有较高的敏感性和特异性。